We therefore conclude that the effect of the ANGPTL4 E40K polymorphism is unlikely diminished to any substantial degree by the independent effects of obesity and T2D on triglyceride levels. The gene discussed is ANGPTL4; the disease is obesity due to melanocortin 4 receptor deficiency.